Export region

Tablet coating material exported to the CIS and Central Asia

EAEU GMP requirements across a region with growing domestic formulation capacity.

Written by the Rglax Pharma technical team, who formulate and manufacture every grade named on this page at our WHO-GMP works in Tahliwal, Una (drug manufacturing licence NNZ/23/238). Reviewed 3 September 2026. Licences and certificates.

Send an export enquiry +91 98821 30484

A tablet with a crack across its face — The markets we supply across the CIS and Central Asia, and the route from Tahliwal. Not a statement of registration in any market.

What this region runs

Uzbekistan and Kazakhstan have both built out domestic formulation capacity over the past decade, much of it aimed at import substitution. The Eurasian Economic Union GMP framework has raised documentation expectations across member states.

Why our range fits it

Buyers here tend to be building or upgrading lines rather than running long established ones, which means the technical service side matters more than the price list. Our published process parameters for conventional as well as auto coaters are directly useful where older equipment is still in service.

What to send us

Tell us the coater you are running, its size and whether it is a conventional or perforated pan. That changes which grade we recommend more than the active does.

Market facts

Markets: Uzbekistan, Kazakhstan, Azerbaijan, Georgia, Armenia, Belarus, Kyrgyzstan
Pharmacopoeia: State pharmacopoeias alongside European Pharmacopoeia references.
Exported from: Plot No. 30, Industrial Area Tahliwal, Himachal Pradesh, India
Licence: NNZ/23/238
Compliance: WHO-GMP Compliance Unit
DMF: U.S.-DMF applied

Regulators you would be working under

EAEU GMP framework
National agencies in Uzbekistan and Kazakhstan

Listed so you know the framework we would be supplying into. It is not a claim that we hold a registration or approval with any of them.

Grades

The 4 grades most asked for in CIS and Central Asia.

Chosen against the climate zone, the product mix and the documentation expectations of the region. Each links to its full page, with the process parameters it was developed on.

AQ-ZWt10 Film coating
Aqueous film coat, extra white
Water base extra white film coat for cores that show through a standard white.
Aqueous extra white film coat developed for tablets where the core colour bleeds through a conventional white film. Calcium and Azithromycin cores are the usual cases. It gives higher opacity at the same build-up.
Base ·
Aqueous
Finish ·
Extra white, high opacity
Formulated against ·
Calcium, Azithromycin
AQ-Z Wb Film coating
Aqueous film coat, white or colour
Water base ready-mix film coat supplied white or in your agreed shade.
General purpose aqueous film coating for immediate release tablets. It is dispersed in purified water and applied as a white or coloured film coat, giving a smooth, glossy surface with well defined logo definition.
Base ·
Aqueous
Finish ·
White or colour, high gloss
ECMS Enteric coating
Enteric coat, methacrylic second bond
Second bond methacrylic enteric system for Mesalamine.
Methacrylic base enteric coating on a second bond, formulated for Mesalamine enteric tablets where release has to be held until a defined point in the intestinal tract.
Base ·
Non-aqueous (solvent)
Finish ·
Enteric film, delayed release
Formulated against ·
Mesalamine
SC-401 Seal and pre-coat
Transparent seal coat and pre-coat
Clear sub-coat laid down before an enteric layer on acid labile cores.
Transparent layer seal coat or pre-coat applied ahead of an enteric coat, specified for the Pantoprazole group. It isolates the core from the enteric polymer and gives the functional layer a uniform surface to build on.
Base ·
Aqueous or non-aqueous
Finish ·
Transparent
Formulated against ·
Pantoprazole group